DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copies of newspaper publication12-01-2024
12-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Issue of Letter of confirmation in lieu of Duplicate share certificate10-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Initmation of loss of share certificates10-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Announcement under Regulation 30 (LODR)-Change in Management
Change in Senior Management Personnel10-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Dr Reddys Laboratories Ltd reply to clarification sought by the exchange
The Exchange had sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing on https://www.business-standard.com dated January 07, 2024 (Link: https://www.business-standard.com/companies/news/dr-reddy-s-recalls-8-000-bottles-of-generic-drug-in-us-over-packaging-error-124010700152_1.html) titled "Dr Reddy's recalls 8,000 bottles of generic drug in US over packaging error".Dr Reddys Laboratories Ltd response is enclosed.09-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Clarification sought from Dr Reddys Laboratories Ltd
The Exchange has sought clarification from Dr Reddys Laboratories Ltd with respect to news article appearing on https://www.business-standard.com dated January 07, 2024 (Link: https://www.business-standard.com/companies/news/dr-reddy-s-recalls-8-000-bottles-of-generic-drug-in-us-over-packaging-error-124010700152_1.html) titled "Dr Reddy''s recalls 8,000 bottles of generic drug in US over packaging error".The reply is awaited.08-01-2024
Dr Reddy's recalls over 8,000 bottles of generic drug in US due to packaging error
The Hyderabad-based drug major is recalling 8,280 bottles of Tacrolimus capsules from the US market for "presence of foreign tablets/capsules" in the affected lot07-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 201505-01-2024
DR.REDDY'S LABORATORIES LTD. - 500124 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants Regulations), 201804-01-2024
Dr. Reddy's Laboratories acquires MenoLabs from Amyris
Dr. Reddy's acquisition of MenoLabs includes products tailored for perimenopause, menopause04-01-2024